combretastatin has been researched along with ng-nitroarginine methyl ester in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, LE; Bhatt, RS; Chang, S; Dvorak, AM; Dvorak, HF; Jaminet, SC; Kang, PM; Masse, E; Nagy, JA; Sciuto, TE; Shen, M; Sitohy, B | 1 |
1 other study(ies) available for combretastatin and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.
Topics: Adenoviridae; Angiogenesis Inhibitors; Animals; Bibenzyls; Blood Vessels; Cell Death; Cell Proliferation; Endothelial Cells; Female; Hypertension; Mice, Inbred C57BL; Mice, Nude; Microvessels; Models, Biological; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |